Logo image of QTTB

Q32 BIO INC (QTTB) Stock Fundamental Analysis

USA - Nasdaq - NASDAQ:QTTB - US7469641051 - Common Stock

3.9017 USD
-0.09 (-2.21%)
Last: 1/28/2026, 12:48:31 PM
Fundamental Rating

1

We assign a fundamental rating of 1 out of 10 to QTTB. QTTB was compared to 525 industry peers in the Biotechnology industry. Both the profitability and financial health of QTTB have multiple concerns. QTTB is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

0

1. Profitability

1.1 Basic Checks

  • In the past year QTTB has reported negative net income.
  • In the past year QTTB has reported a negative cash flow from operations.
  • In the past 5 years QTTB always reported negative net income.
  • QTTB had a negative operating cash flow in each of the past 5 years.
QTTB Yearly Net Income VS EBIT VS OCF VS FCFQTTB Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -20M -40M -60M -80M -100M

1.2 Ratios

  • With a Return On Assets value of -75.58%, QTTB is not doing good in the industry: 65.14% of the companies in the same industry are doing better.
Industry RankSector Rank
ROA -75.58%
ROE N/A
ROIC N/A
ROA(3y)-62.55%
ROA(5y)-56.34%
ROE(3y)-332.65%
ROE(5y)-224.01%
ROIC(3y)N/A
ROIC(5y)N/A
QTTB Yearly ROA, ROE, ROICQTTB Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 -200 -400 -600 -800

1.3 Margins

  • QTTB does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
QTTB Yearly Profit, Operating, Gross MarginsQTTB Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 -2K -4K -6K -8K

3

2. Health

2.1 Basic Checks

  • QTTB does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • Compared to 1 year ago, QTTB has more shares outstanding
  • The number of shares outstanding for QTTB has been reduced compared to 5 years ago.
  • Compared to 1 year ago, QTTB has a worse debt to assets ratio.
QTTB Yearly Shares OutstandingQTTB Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M 50M
QTTB Yearly Total Debt VS Total AssetsQTTB Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M

2.2 Solvency

  • Based on the Altman-Z score of -5.81, we must say that QTTB is in the distress zone and has some risk of bankruptcy.
  • Looking at the Altman-Z score, with a value of -5.81, QTTB is doing worse than 63.05% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -5.81
ROIC/WACCN/A
WACC8.86%
QTTB Yearly LT Debt VS Equity VS FCFQTTB Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M -100M 200M

2.3 Liquidity

  • A Current Ratio of 4.71 indicates that QTTB has no problem at all paying its short term obligations.
  • QTTB has a Current ratio (4.71) which is comparable to the rest of the industry.
  • A Quick Ratio of 4.71 indicates that QTTB has no problem at all paying its short term obligations.
  • The Quick ratio of QTTB (4.71) is comparable to the rest of the industry.
Industry RankSector Rank
Current Ratio 4.71
Quick Ratio 4.71
QTTB Yearly Current Assets VS Current LiabilitesQTTB Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M 250M

1

3. Growth

3.1 Past

  • QTTB shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 84.96%, which is quite impressive.
  • The Revenue for QTTB has decreased by -100.00% in the past year. This is quite bad
EPS 1Y (TTM)84.96%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%58.9%
Revenue 1Y (TTM)-100%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

  • Based on estimates for the next years, QTTB will show a very strong growth in Earnings Per Share. The EPS will grow by 20.32% on average per year.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y85.2%
EPS Next 2Y36.4%
EPS Next 3Y20.32%
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
QTTB Yearly Revenue VS EstimatesQTTB Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2019 2020 2021 2022 2023 10M 20M 30M
QTTB Yearly EPS VS EstimatesQTTB Yearly EPS VS EstimatesYearly EPS VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 -20 -40 -60 -80

1

4. Valuation

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for QTTB. In the last year negative earnings were reported.
  • Also next year QTTB is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
QTTB Price Earnings VS Forward Price EarningsQTTB Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
QTTB Per share dataQTTB EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share -1 -2 -3 -4 -5

4.3 Compensation for Growth

  • QTTB's earnings are expected to grow with 20.32% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y36.4%
EPS Next 3Y20.32%

0

5. Dividend

5.1 Amount

  • QTTB does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

Q32 BIO INC / QTTB FAQ

Can you provide the ChartMill fundamental rating for Q32 BIO INC?

ChartMill assigns a fundamental rating of 1 / 10 to QTTB.


What is the valuation status for QTTB stock?

ChartMill assigns a valuation rating of 1 / 10 to Q32 BIO INC (QTTB). This can be considered as Overvalued.


How profitable is Q32 BIO INC (QTTB) stock?

Q32 BIO INC (QTTB) has a profitability rating of 0 / 10.


What is the financial health of Q32 BIO INC (QTTB) stock?

The financial health rating of Q32 BIO INC (QTTB) is 3 / 10.